0001437749-18-017771.txt : 20181002
0001437749-18-017771.hdr.sgml : 20181002
20181002160228
ACCESSION NUMBER: 0001437749-18-017771
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181001
FILED AS OF DATE: 20181002
DATE AS OF CHANGE: 20181002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rice Michael
CENTRAL INDEX KEY: 0001389512
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 181101248
MAIL ADDRESS:
STREET 1: C/O BIOLIFE SOLUTIONS, INC.
STREET 2: 171 FRONT STREET
CITY: OWEGO
STATE: NY
ZIP: 13827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-10-01
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001389512
Rice Michael
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY, SUITE 310
BOTHELL
WA
98021
1
1
President & CEO
Common Stock
2018-10-01
4
M
0
12540
1.26
A
152057
D
Common Stock
2018-10-01
4
S
0
12540
17.57
D
139517
D
Employee Stock Option
1.26
2018-10-01
4
M
0
12540
0
D
2019-02-26
Common Stock
12540
29562
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.75, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Option vested as to 13,661 shares on February 27, 2010, and vested as to one thirty-sixth of the remaining balance of 40,981 shares on the 27th day of each of the ensuing 36 months
/s/ Michael Rice
2018-10-02